SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the U.S. Food and Drug...
Read More Details
Finally We wish PressBee provided you with enough information of ( Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection )
Also on site :
- 'Full House' Star, 43, Makes Rare Comment About Ashley Olsen
- '90s Rapper and Actor, 61, Makes Rare Red Carpet Appearance
- A Gaza-bound aid boat carrying Greta Thunberg and other activists has been diverted to Israel